• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。

Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.

机构信息

Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Respiration, Harbin City First Hospital, Harbin, China.

出版信息

Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.

DOI:10.1159/000508398
PMID:33207356
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has become a global emerging infectious disease.

OBJECTIVES

To analyze the initial clinical characteristics of COVID-19 suspected and confirmed patients on admission in order to find out which kinds may be more likely to get positive nucleic acid testing results, and to explore the risk factors associated with all-cause death.

METHODS

Medical records from 309 highly suspected cases with pneumonia were collected from February 13, 2020, to March 14, 2020, in a COVID-19-designated hospital of Wuhan. The majority of the clinical data were collected on the first day of hospital admission.

RESULTS

Of 309 patients with median age 64 years (interquartile ranges [IQR], 53-72 years), 111 patients (35.9%) were confirmed by nucleic acid testing (median age 64 years, IQR: 56-71 years; 48 males). Of those 111 patients, 13 (11.7%) patients died. In multivariate analysis, factors associated with positive testing included fatigue (odds ratios [OR] = 3.14; 95% confidence interval [CI]: 1.88-5.24, p < 0.001), cough (OR = 0.55; 95% CI: 0.32-0.95, p = 0.032), no less than 1 comorbidity (OR = 1.77; 95% CI: 1.06-2.98, p = 0.030), and severe pneumonia (OR = 2.67; 95% CI: 1.20-5.97, p = 0.016). Furthermore, age, dyspnea, noneffective antibiotic treatment, white blood cell, lymphocyte, platelets, and organ dysfunction (e.g., higher lactate dehydrogenase) were significantly associated with all-cause in-hospital death in patients with COVID-19.

CONCLUSION

Patients with severe forms of this disease were more likely to get positive results. Age and organ dysfunction were associated with a greater risk of death.

摘要

背景

2019 年冠状病毒病(COVID-19)已成为一种全球性新发传染病。

目的

分析 COVID-19 疑似和确诊患者入院时的初始临床特征,以确定哪些患者更有可能获得阳性核酸检测结果,并探讨与全因死亡相关的危险因素。

方法

2020 年 2 月 13 日至 2020 年 3 月 14 日,从武汉市一家 COVID-19 指定医院收集了 309 例肺炎高度疑似病例的病历。大多数临床数据是在入院第一天收集的。

结果

309 例患者的中位年龄为 64 岁(四分位距 [IQR]:53-72 岁),其中 111 例(35.9%)通过核酸检测确诊(中位年龄 64 岁,IQR:56-71 岁;男性 48 例)。这 111 例患者中,有 13 例(11.7%)患者死亡。多变量分析显示,阳性检测的相关因素包括乏力(比值比 [OR] = 3.14;95%置信区间 [CI]:1.88-5.24,p < 0.001)、咳嗽(OR = 0.55;95%CI:0.32-0.95,p = 0.032)、至少存在 1 种合并症(OR = 1.77;95%CI:1.06-2.98,p = 0.030)和重症肺炎(OR = 2.67;95%CI:1.20-5.97,p = 0.016)。此外,年龄、呼吸困难、无效抗生素治疗、白细胞、淋巴细胞、血小板和器官功能障碍(如,更高的乳酸脱氢酶)与 COVID-19 患者院内全因死亡显著相关。

结论

患有严重疾病的患者更有可能获得阳性结果。年龄和器官功能障碍与死亡风险增加相关。

相似文献

1
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.
2
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
3
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
4
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
5
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
6
Initial Observations of COVID-19 in US Children.美国儿童新冠病毒病的初步观察
Hosp Pediatr. 2020 Oct;10(10):902-905. doi: 10.1542/hpeds.2020-000257. Epub 2020 Jul 7.
7
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.伴有糖尿病的 COVID-19 患者的实验室检查结果特征。
Diabetes Res Clin Pract. 2020 Sep;167:108351. doi: 10.1016/j.diabres.2020.108351. Epub 2020 Jul 22.
8
Study on Laboratory Indicators Related to Lung Injury of Corona Virus Disease 2019.关于 2019 年冠状病毒疾病肺损伤相关实验室指标的研究。
Clin Lab. 2021 Jan 1;67(1). doi: 10.7754/Clin.Lab.2020.200606.
9
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.西班牙大流行中期有症状的孕妇的 COVID-19 感染:一项回顾性分析。
Ginekol Pol. 2020;91(12):755-763. doi: 10.5603/GP.a2020.0130.
10
Clinical characteristics and outcomes of cancer patients with COVID-19.COVID-19 癌症患者的临床特征和结局。
J Med Virol. 2020 Oct;92(10):2067-2073. doi: 10.1002/jmv.25972. Epub 2020 Jun 2.

引用本文的文献

1
Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains.2023-2024 季节性流感疫苗对流行的 H3N2 流感病毒株的中和效力。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2380111. doi: 10.1080/21645515.2024.2380111. Epub 2024 Aug 29.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study.
新型冠状病毒肺炎患者血清肝功能变化:一项为期1年的随访研究。
Infect Drug Resist. 2022 Apr 15;15:1857-1870. doi: 10.2147/IDR.S356181. eCollection 2022.
4
Predictive Score of Risk Associated with Progression of Patients with COVID-19 Pneumonia in Wuhan, China: the ALA Score.中国武汉新冠肺炎肺炎患者病情进展相关风险的预测评分:ALA评分
Arab J Sci Eng. 2021 Jun 28:1-9. doi: 10.1007/s13369-021-05808-z.